Prosecution Insights
Last updated: August 15, 2026
Application No. 18/135,447

SYSTEMS, DEVICES AND RELATED METHODS OF COORDINATING INSULIN MANAGEMENT AND DELIVERY MODES IN FASTING & NON-FASTING PERIODS

Non-Final OA §112
Filed
Apr 17, 2023
Priority
Apr 18, 2022 — provisional 63/332,001
Examiner
OLYNICK, DAVID
Art Unit
3741
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Luna Health Inc.
OA Round
2 (Non-Final)
78%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
188 granted / 241 resolved
+8.0% vs TC avg
Strong +24% interview lift
Without
With
+24.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 4m
Avg Prosecution
10 currently pending
Career history
252
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
50.7%
+10.7% vs TC avg
§102
21.3%
-18.7% vs TC avg
§112
25.4%
-14.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 241 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Response to Amendment This Office action is responsive to the RCE filed 22 June 2026. Claims 3, 11, 24 and 31-41 are canceled. Claims 1-2, 4-10, 12-23 and 25-30 are pending and are examined. Claim Rejections - 35 USC § 112 Claim 14 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 14 depends from claim 1 and recites “the evaluated blood glucose measurement is evaluated at least in part by fitting received blood glucose measurements within a predetermined timeframe to a trend having a median slope selected from a plurality of regression fit slopes for different rolling subsets of received blood glucose measurements within the predetermined timeframe.” It is not clear whether “a trend” is different from the “downward trend” in claim 1. The specification allows for trends that are not downward. Nevertheless, given how claim was amended to recite “projecting a downward trend of a plurality of received blood glucose measurements and adding the downward trend to one of the plurality of received blood glucose measurements to obtain an evaluated blood glucose measurement” Examiner suspects “a trend” in claim 14 is referring to the downward trend in claim 1 and not a different trend. Allowable Subject Matter Claim 1-2, 4-10, 12-13, 15-23 and 25-30 are allowed. Claim 14 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DAVID OLYNICK whose telephone number is (571)272-2355. The examiner can normally be reached M-F: 7:30 am-5 pm (ET). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Phuttiwat Wongwian can be reached at (571) 270-5426. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DAVID P. OLYNICK/Primary Examiner, Art Unit 3741
Read full office action

Prosecution Timeline

Apr 17, 2023
Application Filed
Nov 21, 2025
Non-Final Rejection mailed — §112
Jan 20, 2026
Response Filed
Apr 10, 2026
Examiner Interview (Telephonic)
Jun 22, 2026
Request for Continued Examination
Jun 26, 2026
Response after Non-Final Action
Jul 22, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12687131
GAS TURBINE ENGINE
1y 3m to grant Granted Jul 21, 2026
Patent 12680465
ELECTRIC MACHINE ASSEMBLY FOR A TURBINE ENGINE
2y 1m to grant Granted Jul 14, 2026
Patent 12680508
HYBRID TURBOFAN ENGINE WITH A PLANETARY GEARSET FOR BLENDING POWER BETWEEN AN ELECTRIC OUTPUT AND VARIABLE-THRUST BYPASS FAN
1y 8m to grant Granted Jul 14, 2026
Patent 12673163
AUTOINJECTOR WITH A SEPARABLE ELECTRONICS MODULE
2y 5m to grant Granted Jul 07, 2026
Patent 12674422
GAS TURBINE ENGINE
1y 3m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
78%
Grant Probability
99%
With Interview (+24.0%)
2y 4m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 241 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month